Drug Transporter (DT) Information

General Information of DT
DT ID DTD0020
Gene Name SLC10A2
Protein Name Apical sodium-dependent bile acid transporter
Gene ID
6555
UniProt ID
Q12908
TCDB ID
2.A.28.1.2
3D Structure

Modelled DT Structure

Method: homology modeling

Template PDB: 3ZUY_A

Identity: 33.333%

Minimized Score: -495.929 kcal/mol

Detail: Structure Info

Synonyms ASBT; IBAT; ISBT; Ileal Na(+)/bile acid cotransporter; Ileal sodium-dependent bile acid transporter; Ileal sodium/bile acid cotransporter; NTCP2; Na(+)-dependent ileal bile acid transporter; PBAM; SLC10A2; Sodium/taurocholate cotransporting polypeptide, ileal; Solute carrier family 10 member 2
DT Family Bile Acid:Na(+) Symporter (BASS) Family ;
Function This transporter plays a critical role in the sodium-dependent reabsorption of bile acids from the lumen of the small intestine.
Endogenous Substrate(s) Bile acids; Bile conjugates; Cholate; Glycochenodeoxycholate
Variability Data of This Drug Transporter (DT)

Regulatory Variability Data of This DT (VARIDT 3.0)

(α) Microbiota Influence of This DT
Microbiota Influence (MBI)

(β) Post-translational Modification of This DT
Post-translational Modification (PTM)

(γ) Transcriptional Regulation of This DT
Transcriptional Regulation (TSR)

(δ) Epigenetic Regulation of This DT
Epigenetic Regulation (EGR)

(ε) Exogenous Modulation of This DT
Exogenous Modulation (EGM)

Structural Variability Data of This DT (VARIDT 2.0)

(β) Inter-species Structural Differences
Inter-species Structural Differences (ISD)

General Variability Data of This DT (VARIDT 1.0)

(α) Genetic Polymorphisms of This DT
Genetic Polymorphisms of This DT (GPD)

(β) Disease-specific Protein Abundances of This DT
Disease-specific Protein Abundances of This DT (DPAD)

(γ) Species- and Tissue-specific DT Abundances
Species/Tissue-specific Protein Abundances of This DT (S/TPAD)
Molecular Transporting Profile of This DT

Full List of Drug(s) Transported by This DT

 Approved Drug

 Click to Show/Hide the Full List of Drug:            2 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Cholic acid
 Approved Drug Info Synthesis disorders 5C52.10 [1]
Deoxycholic acid
 Approved Drug Info Fat below the chin 5B80 [2]

 Withdrawn, Discontinued or Preclinical Drug

 Click to Show/Hide the Full List of Drug:            3 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Glycodeoxycholic acid
 Preclinical Drug Info Asthma CA23 [1]
Sodium taurocholate
 Preclinical Drug Info Type 2 diabetes 5A11 [3]
Taurocholic acid
 Terminated Drug Info Type 2 diabetes 5A11 [3]

Endogenous Metabolites (EMs) Handled by This DT

 Endogenous Metabolites (EMs)

 Click to Show/Hide the Full List of EMs:            1 EMs in Total
EM Name PubChem CID Detail Experimental Material Ref
Bile acid unspecific N.A. EM Info Identified using actively drinking cirrhotic patients [4]

Drug-DT Affinity Assessed by Cell Line

 Withdrawn, Discontinued or Preclinical Drug

 Click to Show/Hide the Full List of Drug:            5 Drugs in Total
Drug Name Highest Status Detail Cell Line Affinity Ref
Sodium taurocholate Preclinical Drug Info Human embryonic kidney cells (HEK293)-ASBT Km = 9.4 microM [3]
Sodium taurocholate Preclinical Drug Info Monkey kidney fibroblast-like cell (COS)1-ASBT Km = 13.3 microM [5]
Sodium taurocholate Preclinical Drug Info Monkey kidney fibroblast-like cell (COS)7-ASBT Km = 16 microM [6]
Taurocholic acid Terminated Drug Info Human embryonic kidney cells (HEK293)-ASBT Km = 9.4 microM [3]
Taurocholic acid Terminated Drug Info Monkey kidney fibroblast-like cell (COS)1-ASBT Km = 13.3 microM [5]
References
1 Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol. 1998 Jan;274(1):G157-69.
2 Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery. Biomaterials. 2018 Jan;151:13-23.
3 Identification of a region of the ileal-type sodium/bile acid cotransporter interacting with a competitive bile acid transport inhibitor. Biochemistry. 2002 Dec 17;41(50):14916-24.
4 Continued Alcohol Misuse in Human Cirrhosis is Associated with an Impaired Gut-Liver Axis. Alcohol Clin Exp Res. 2017 Nov;41(11):1857-1865.
5 Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol. 1998 Jan;274(1 Pt 1):G157-69.
6 Analysis of the ileal bile acid transporter gene, SLC10A2, in subjects with familial hypertriglyceridemia. Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):2039-45.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.